The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study

Hélène Haguet, Céline Bouvy, Anne Sophie Delvigne, Elise Modaffari, Adeline Wannez, Pierre Sonveaux, Jean Michel Dogné, Jonathan Douxfils

Résultats de recherche: Contribution à un journal/une revueArticleRevue par des pairs

40 Téléchargements (Pure)

Empreinte digitale

Examiner les sujets de recherche de « The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study ». Ensemble, ils forment une empreinte digitale unique.

Pharmacology, Toxicology and Pharmaceutical Science